Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic variants in m6A regulators are associated with gastric cancer risk
Xiaowei Wang, Dan Guan, Dafei Wang, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 3, pp. 1081-1088
Closed Access | Times Cited: 21

Showing 21 citing articles:

Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Chao‐Yue Sun, Cao Di, Bin-Bin Du, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2744-2758
Open Access | Times Cited: 52
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
Meiqi Duan, Haiyang Liu, Shasha Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 890-920
Open Access | Times Cited: 23
Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease
Yanyao Deng, Hongwei Zhu, Le Xiao, et al.
Aging (2021) Vol. 13, Iss. 21, pp. 24086-24100
Open Access | Times Cited: 37
N6‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
Shenghua Dong, Yutong Wu, Yadi Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 538-559
Open Access | Times Cited: 34
IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway
Dong Liu, A-Dong Xia, Le-Ping Wu, et al.
Cellular Signalling (2022) Vol. 94, pp. 110313-110313
Closed Access | Times Cited: 27
IGF2BP3 prefers to regulate alternative splicing of genes associated with the progression of gastric cancer in AGS cells
Xiangyue Zeng, Yu Zhang, Tiannake Shapaer, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer
Wenzhang Wu, Fan Zhang, Jun Zhao, et al.
Experimental Cell Research (2022) Vol. 415, Iss. 2, pp. 113115-113115
Closed Access | Times Cited: 19
Genetic variants in m6A regulator genes confer susceptibility and progression of HCC in a Northern Chinese population
Guohua Ji, Chao Gao, Yi Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
N6-methylation in the development, diagnosis, and treatment of gastric cancer
Jiaxin Wang, Guiping Zhao, Yan Zhao, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 5-21
Open Access | Times Cited: 3
Role of N6-methyladenosine RNA modification in gastric cancer
Siqi Ding, Xue-Ping Zhang, Jun‐Peng Pei, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Genetic variants of m6A modification genes are associated with survival of HBV‐related hepatocellular carcinoma
Shuyan Liu, Jian-Xu Li, Moqin Qiu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
Recent advances in noncoding RNA modifications of gastrointestinal cancer
Tomoaki Hara, Sikun Meng, Yasuko Arao, et al.
Cancer Science (2024)
Open Access | Times Cited: 2
Research Progress for RNA Modifications in Physiological and Pathological Angiogenesis
Hui-Ming Chen, Hang Li, Meng-Xian Lin, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Progress and application of epitranscriptomic m 6 A modification in gastric cancer
Yitian Xu, Chen Huang
RNA Biology (2022) Vol. 19, Iss. 1, pp. 885-896
Open Access | Times Cited: 6
Genome-Wide Identification of m6A-Associated Single-Nucleotide Polymorphisms in Colorectal Cancer
Hongying Zhao, Jinying Jiang, Mingshan Wang, et al.
Pharmacogenomics and Personalized Medicine (2021) Vol. Volume 14, pp. 887-892
Open Access | Times Cited: 7
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
Jiancheng Lv, Qiang Song, Kexin Bai, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
Yi Zhang, Wendong Gu, Yingjie Shao
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Integrative analyses of N6‐methyladenosine‐associated single‐nucleotide polymorphisms (m6A‐SNPs) identify tumor suppressor gene AK9 in lung cancer
Tingting Hua, Chang Zhang, Yating Fu, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 3, pp. 538-548
Open Access | Times Cited: 2
Evaluation of genetic variants in nucleosome remodeling and deacetylase (NuRD) complex subunits encoding genes and gastric cancer susceptibility
Yujuan Zhang, Guoquan Tao, Ping Liu, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1739-1749
Closed Access | Times Cited: 3
m6A-related lncRNAs predict prognosis and indicate cell cycle in gastric cancer
Wan Dong, Lingnan He, Cheng Guo, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics
Haotian Jiang, Yuan Li, Yinghui Liu, et al.
Future Oncology (2022) Vol. 18, Iss. 17, pp. 2141-2153
Open Access | Times Cited: 2
Page 1

Scroll to top